<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="ArialMT" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="SymbolMT" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font7" size="9" family="GillSans,BoldItalic" color="#000000"/>
<text top="41" left="55" width="70" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>Nuclear Receptor</i></text>
<text top="41" left="125" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2007, </text>
<text top="41" left="153" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>5</b></text>
<text top="41" left="158" width="7" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:1</text>
<text top="41" left="370" width="184" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.nuclear-receptor.com/content/5/1/1</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t6" reading_order_no="135" segment_no="8" tag_type="text">Page 6 of 13</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="136" segment_no="9" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">extended directly to insulin production, as PPARs are</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">involved in controlling glucose-stimulated insulin release,</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">a process that is modulated by fatty acids and may involve</text>
<text top="122" left="55" width="97" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text">UCPs: increased PPAR </text>
<text top="119" left="153" width="6" height="12" font="font5" id="p1_t12" reading_order_no="9" segment_no="2" tag_type="text">α</text>
<text top="122" left="159" width="137" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="2" tag_type="text"> activity is associated with down</text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="2" tag_type="text">regulation of insulin production during fasting, while</text>
<text top="145" left="55" width="26" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="2" tag_type="text">PPAR </text>
<text top="143" left="83" width="4" height="12" font="font5" id="p1_t16" reading_order_no="13" segment_no="2" tag_type="text">γ</text>
<text top="145" left="87" width="209" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="2" tag_type="text"> islet over-expression can also suppress insulin</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="2" tag_type="text">release [<a href="">87,88</a>]. Interestingly, saturated fat is far more</text>
<text top="169" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="2" tag_type="text">insulinotropic than unsaturated fa<a href="">t [89], whi</a>ch might</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="2" tag_type="text">suggest that PPARs are more effective at reducing insulin</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="2" tag_type="text">production in response to unsaturated fats. This is in</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="2" tag_type="text">keeping with the susceptibility of unsaturated fats to oxi-</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="2" tag_type="text">dative damage. In contrast, saturated fat is less effective</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="2" tag_type="text">than unsaturated fat at stimulating the incretin, glucagon-</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="2" tag_type="text">like peptide-1 (GLP-1), from the gut <a href="">[90]</a>. The biological</text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="2" tag_type="text">activities of GLP-1 include stimulation of glucose-depend-</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="2" tag_type="text">ent insulin secretion and insulin biosynthesis, inhibition</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="2" tag_type="text">of glucagon secretion and gastric emptying, and inhibi-</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="2" tag_type="text">tion of food intake. This may suggest an evolved bias</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="2" tag_type="text">towards unsaturated dietary fat intake from the gut, but an</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="2" tag_type="text">internal system to react to nascent saturated fat produced</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="2" tag_type="text">from glucose (or fructose): i.e. we are far more able to tol-</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="2" tag_type="text">erate ingestion of unsaturated fat, compared to saturated</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="2" tag_type="text">fat – but the system is designed to recognise and deal with</text>
<text top="357" left="55" width="43" height="9" font="font6" id="p1_t35" reading_order_no="32" segment_no="2" tag_type="text"><i>de novo </i></text>
<text top="357" left="98" width="198" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="2" tag_type="text">saturated fat generated from carbohydrate.</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="2" tag_type="text">Human data suggest that rosiglitazone can activate desat-</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="2" tag_type="text">urases, so reducing levels of saturated fat in the system</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="2" tag_type="text"><a href="">[91], wh</a>ich would further indicate that reduction of</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="2" tag_type="text">excess saturated fat is a biological imperative.</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="6" tag_type="text">We propose that at it simplest, muscle insulin sensitivity</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="6" tag_type="text">may result in increased thermogenesis through futile</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="6" tag_type="text">cycling and thus, would be associated with an 'unthrifty'</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="6" tag_type="text">genotype. Key in either the thrifty, or unthrifty genotypes</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="6" tag_type="text">(as indicated by the PPAR ala/pro mutation), would be</text>
<text top="486" left="55" width="204" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="6" tag_type="text">the role of the PPARs: increased adipose PPAR </text>
<text top="483" left="259" width="4" height="12" font="font5" id="p1_t47" reading_order_no="44" segment_no="6" tag_type="text">γ</text>
<text top="486" left="263" width="33" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="6" tag_type="text"> activity</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="6" tag_type="text">would result in better fat storage (adipose insulin sensitiv-</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="6" tag_type="text">ity), whereas an improved ability to burn fat in muscle</text>
<text top="521" left="55" width="30" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="6" tag_type="text">(PPAR </text>
<text top="519" left="85" width="6" height="12" font="font5" id="p1_t52" reading_order_no="49" segment_no="6" tag_type="text">α</text>
<text top="521" left="91" width="4" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="6" tag_type="text">/</text>
<text top="519" left="95" width="5" height="12" font="font5" id="p1_t54" reading_order_no="51" segment_no="6" tag_type="text">δ</text>
<text top="521" left="100" width="196" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="6" tag_type="text">) might be associated with better muscle insu-</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="6" tag_type="text">lin sensitivity and less efficient feed efficiency (but a better</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="6" tag_type="text">tolerance to cold). Hence, by modulating tissue-specific</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="6" tag_type="text">fatty acid metabolism and storage, PPARs are able to max-</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="6" tag_type="text">imise FOXO activity and thus optimise resistance to oxi-</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="6" tag_type="text">dative stress by reducing the need for insulin. One</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="6" tag_type="text">obvious exception to this is the mutually suppressive</text>
<text top="604" left="55" width="75" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="6" tag_type="text">effects of PPAR </text>
<text top="601" left="130" width="4" height="12" font="font5" id="p1_t63" reading_order_no="60" segment_no="6" tag_type="text">γ</text>
<text top="604" left="134" width="162" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="6" tag_type="text"> and FOXO in adipose tissue <a href="">[22];</a></text>
<text top="615" left="55" width="70" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="6" tag_type="text">increased PPAR </text>
<text top="612" left="125" width="4" height="12" font="font5" id="p1_t66" reading_order_no="63" segment_no="6" tag_type="text">γ</text>
<text top="615" left="129" width="167" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="6" tag_type="text"> activity would act to store fatty acids,</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="6" tag_type="text">while still maintaining an anti-inflammatory effect</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="6" tag_type="text">(reduce oxidative stress) by suppression of NFkB. Cer-</text>
<text top="651" left="55" width="66" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="6" tag_type="text">tainly, basal NF</text>
<text top="648" left="121" width="5" height="12" font="font5" id="p1_t71" reading_order_no="68" segment_no="6" tag_type="text">κ</text>
<text top="651" left="126" width="170" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="6" tag_type="text">B activity increases during adipocyte dif-</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="6" tag_type="text">ferentiation [<a href="">92]</a>. This would suggest a possible adipose-</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="6" tag_type="text">inflammatory paradigm, whereby increased NFkB activity</text>
<text top="686" left="55" width="234" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="6" tag_type="text">could conceivably suppress both FOXO and PPAR </text>
<text top="683" left="290" width="4" height="12" font="font5" id="p1_t76" reading_order_no="73" segment_no="6" tag_type="text">γ</text>
<text top="686" left="294" width="3" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="6" tag_type="text">,</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="6" tag_type="text">resulting in 'inflammatory' lipolysis. During starvation,</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t79" reading_order_no="76" segment_no="6" tag_type="text">FOXO would be expected to suppress both NFkB and</text>
<text top="721" left="55" width="26" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="6" tag_type="text">PPAR </text>
<text top="718" left="83" width="4" height="12" font="font5" id="p1_t81" reading_order_no="78" segment_no="6" tag_type="text">γ</text>
<text top="721" left="87" width="210" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="6" tag_type="text"> and result in 'starvation' lipolysis. However, in</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="3" tag_type="text">obesity, this natural suppression of inflammation is lost</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="3" tag_type="text">due to the high adipose-related inflammatory signal,</text>
<text top="110" left="313" width="123" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="3" tag_type="text">which suppresses both PPAR </text>
<text top="107" left="436" width="4" height="12" font="font5" id="p1_t86" reading_order_no="83" segment_no="3" tag_type="text">γ</text>
<text top="110" left="440" width="114" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="3" tag_type="text"> and FOXO: this could lead</text>
<text top="122" left="313" width="116" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="3" tag_type="text">to the metabolic syndrome.</text>
<text top="146" left="313" width="229" height="9" font="font7" id="p1_t89" reading_order_no="86" segment_no="4" tag_type="title"><i><b>The metabolic syndrome; PPARs keep the acute phase </b></i></text>
<text top="157" left="313" width="73" height="9" font="font7" id="p1_t90" reading_order_no="87" segment_no="4" tag_type="title"><i><b>response in check</b></i></text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="5" tag_type="text">It has been suggested that in addition to the 'thrifty' geno-</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="5" tag_type="text">type, another adaptation may also be needed to develop</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="5" tag_type="text">the metabolic syndrome, and that is a 'high cytokine</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="5" tag_type="text">responder' genotype, with an improved ability to resist</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="5" tag_type="text">injury (i.e. a stronger inflammatory res<a href="">ponse) [93</a>]. It has</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="5" tag_type="text">been known for many years that injury can result in pro-</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="5" tag_type="text">found insulin resistance and is associated with the APR,</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="5" tag_type="text">which is a systemic inflammatory injury response to pro-</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="5" tag_type="text">tect the host (being both haemostatic and anti-microbial)</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="5" tag_type="text">characterised by the hepatic production of acute phase</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="5" tag_type="text">proteins (e.g. c-reactive peptide, CRP) and glucose,</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="5" tag_type="text">increased cytokine production and turnover of protein,</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="5" tag_type="text">glycerol free and fatty acids, and has been called the</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="5" tag_type="text">'hypermetabolic res<a href="">ponse' [94,95]. This 'hype</a>rmetabolic'</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t105" reading_order_no="102" segment_no="5" tag_type="text">(catabolic) state can be mimicked by injection of the stress</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="5" tag_type="text">hormones cortisol, glucagon and ephedrine in human</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t107" reading_order_no="104" segment_no="5" tag_type="text">voluntee<a href="">rs [96</a>]. However, this 'hypermetabolic' state is</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t108" reading_order_no="105" segment_no="5" tag_type="text">usually associated with increased thermogenesis (pyrexia)</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t109" reading_order_no="106" segment_no="5" tag_type="text">and is anorexic, and probably involves inflammatory-</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t110" reading_order_no="107" segment_no="5" tag_type="text">mediated modulation of appetite systems, such as the</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t111" reading_order_no="108" segment_no="5" tag_type="text">melanocortin pathway [<a href="">97]</a>; this is clearly not the case in</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t112" reading_order_no="109" segment_no="5" tag_type="text">the metabolic syndrome. Interestingly, leptin is known to</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t113" reading_order_no="110" segment_no="5" tag_type="text">mediate the effects of lipopolysaccharide (LPS) induced</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t114" reading_order_no="111" segment_no="5" tag_type="text">anorexia and <a href="">fever [98], b</a>ut central leptin (and insulin)</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t115" reading_order_no="112" segment_no="5" tag_type="text">resistance is a common finding in obesity and could be</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t116" reading_order_no="113" segment_no="5" tag_type="text">related to leptin itself via effects on phosphatidylinositol</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t117" reading_order_no="114" segment_no="5" tag_type="text">3-kinase (PI3K) and phosphodiesterase 3B (PDE3B) activ-</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t118" reading_order_no="115" segment_no="5" tag_type="text">ities and reduction in cyclic AMP (cAMP) [<a href="">99] and/or th</a>e</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t119" reading_order_no="116" segment_no="5" tag_type="text">pro-inflammatory effects of a high fat diet [<a href="">100]. Th</a>is</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t120" reading_order_no="117" segment_no="5" tag_type="text">might also represent a another thrifty adaptation to</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t121" reading_order_no="118" segment_no="5" tag_type="text">ensure a high state of 'inflammatory readiness', but con-</text>
<text top="533" left="313" width="109" height="9" font="font4" id="p1_t122" reading_order_no="119" segment_no="5" tag_type="text">servation of energy stores.</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t123" reading_order_no="120" segment_no="7" tag_type="text">It was suggested by Pickup and colleagues in 1997 that</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t124" reading_order_no="121" segment_no="7" tag_type="text">'syndrome X' (now called the metabolic syndrome) was in</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t125" reading_order_no="122" segment_no="7" tag_type="text">fact a disease caused by the chronic activation of the</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t126" reading_order_no="123" segment_no="7" tag_type="text">innate immune system and contributed to the hypertrig-</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t127" reading_order_no="124" segment_no="7" tag_type="text">lyceridaemia, low HDL cholesterol, hypertension, glucose</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t128" reading_order_no="125" segment_no="7" tag_type="text">intolerance, insulin resistance and accelerated atheroscle-</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t129" reading_order_no="126" segment_no="7" tag_type="text">rosis of NIDDM [<a href="">101]. This hypo</a>thesis for the develop-</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t130" reading_order_no="127" segment_no="7" tag_type="text">ment of T2D (and the metabolic syndrome) was further</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t131" reading_order_no="128" segment_no="7" tag_type="text">supported by data from the Athersclerosis Risk in Com-</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t132" reading_order_no="129" segment_no="7" tag_type="text">munities study (ARIC)<a href=""> [102</a>]. Importantly, the APR and</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t133" reading_order_no="130" segment_no="7" tag_type="text">inflammation can result in increased insulin output,</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t134" reading_order_no="131" segment_no="7" tag_type="text">which can in turn suppress the APR – so providing a pos-</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t135" reading_order_no="132" segment_no="7" tag_type="text">sible negative feedback mechanism [<a href="">103</a>]. Interestingly,</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t136" reading_order_no="133" segment_no="7" tag_type="text">IL-6, a potent inflammatory cytokine-inducer of the APR</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t137" reading_order_no="134" segment_no="7" tag_type="text">produced by adipose tissue, is significantly associated</text>
</page>
</pdf2xml>
